Evidence is accumulating that peanut consumption confers health benefits, such as reduction of cardiovascular disease risk and possibly diabetes risk (Jenkins et al., 2008; Mattes et al., 2008). However, peanuts are a high fat, energy dense food and concerns about weight gain are widespread. Although research indicates that other characteristics of peanuts offset these properties, and that peanuts may be incorporated into diets without posing a threat to weight gain (Mattes et al., 2008), concern remains among policymakers, healthcare providers, and consumers. Furthermore, worry exists that eating salted peanuts may elevate blood pressure and that eating honey-roasted peanuts make elevate blood sugar. These fears create substantial obstacles to increased peanut consumption. Recommendations to increase peanut consumption may be made, but if they are not followed, there will be no impact on health. Additional knowledge is needed on: (1) the acceptability of peanuts consumed on a chronic basis, (2) the chronic intake of moderate levels of peanuts and body weight, and 3) the effects of peanuts on blood pressure and blood sugar. The proposed research will examine the acceptability of long-term inclusion of a single form versus varied forms of peanuts in the diet. It is expected that responses will be varied among individuals with different personality characteristics (e.g., prefer sweet versus savory foods, hedonic versus non-hedonic eaters). A better understanding of how different segments of the population choose to include peanuts in their diet and how to optimize long-term consumption should provide insights for better marketing and improved health. Furthermore, it is anticipated that eating salty peanuts will not raise blood pressure and that eating honey-roasted peanuts will not raise blood sugar. Documenting this will add credibility to the evidence that peanuts do not cause weight gain, as well as reinforce recommendations to increase peanut consumption for their health benefits.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
196
Consumption of the given 42 grams of peanuts daily without instructions for use (i.e. with/without meals, etc.)
Purdue University
West Lafayette, Indiana, United States
Change in Weight
Time frame: 2, 4, 6, 8, 10, and 12 weeks
Change in Blood Lipids
Time frame: 4, 8, and 12 weeks
Change in Blood Pressure
Time frame: 2, 4, 6, 8, 10, and 12 weeks
Change in Hedonics of peanut consumption
Participants will rate their liking of the sample each day using a visual analog scale.
Time frame: 12 weeks
Change in Body Composition
Time frame: 2, 4, 6, 8, 10, and 12 weeks
Change in Fasting Blood Glucose
Time frame: 4, 8, and 12 weeks
Change in Cortisol
Time frame: 4, 8, and 12 weeks
Change in Insulin
Time frame: 4, 8, and 12 weeks
Change in Pulse
Time frame: 2, 4, 6, 8, 10, and 12 weeks
Personality Questionnaires
Time frame: At baseline visit
Flavor attribute liking measures
Time frame: At baseline
Compliance
Participants will self-report compliance to study protocol using record sheets.
Time frame: 12 weeks
Appetitive Ratings
Collected on handheld computer
Time frame: 4, 8, and 12 weeks
Consumption Parameters
Participants will note if peanuts were eaten as a meal or snack, at what time, and with what other foods daily.
Time frame: 12 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.